US Pre-Market SEC Filings Roundup — February 10, 2026

11-02-2026

11-02-2026

Sino Green Land Corp. filed an 8-K on February 11, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific transaction details, values, or financial impacts are disclosed. This multi-item filing appears informational without quantified metrics.

11-02-2026

Solstice Advanced Materials Inc. filed a Form 8-K on February 11, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, performance comparisons, transaction details, or directional impacts are disclosed. This multi-item filing provides updates on operations and other events, but lacks quantified data for assessment.

11-02-2026

The company filed an 8-K on February 11, 2026 (AccNo: 0001304280-26-000006), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be an informational earnings-related disclosure without detailed performance data.

11-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 reports Regulation FD Disclosure. No specific details on positions affected, reasons for change, or quantitative impacts are provided.

11-02-2026

BIOXYTRAN, INC filed a Form 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no mentioned positive or negative performance indicators.

11-02-2026

Zura Bio Ltd filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-012935, Size: 8 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided filing information. Critical details such as the content of the Regulation FD disclosure or attached exhibits are NOT_DISCLOSED.

11-02-2026

QXO, Inc. filed a Form 8-K on 2026-02-11 disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, share counts, period-over-period comparisons, or other specific details were provided in the filing summary. This represents a multi-item mandatory and voluntary disclosure with no directional financial impacts disclosed.

11-02-2026

SiteOne Landscape Supply, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-012930), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information.

11-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or performance data are mentioned.

11-02-2026

Hilton Worldwide Holdings Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001585689-26-000005), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative financial data were explicitly stated in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed performance indicators.

11-02-2026

Vertiv Holdings Co filed an 8-K on February 11, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and attaches exhibits, but no specific revenue, earnings, or other metrics are detailed in the provided information. No positive or negative performance data is available.

11-02-2026

KORU Medical Systems, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001161697-26-000038), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No specific details on the nature of amendments, fiscal year change, or contents of exhibits are disclosed. No financial metrics, transaction values, or performance data are provided.

11-02-2026

Apollo Commercial Real Estate Finance, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-045193), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance indicators, scheduled events, or strategic details were disclosed.

11-02-2026

Silicon Valley Acquisition Corp. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-014504, Size: 263 KB), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No quantitative metrics, deal terms, parties, strategic rationale, or performance comparisons (positive, negative, or flat) were mentioned. Sector remains not specified, and all material deal details are NOT_DISCLOSED.

11-02-2026

Tyson Foods, Inc. filed a Form 8-K on 2026-02-11 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details disclosed on the nature of the agreement, events, or exhibits provided in the available information. No quantitative metrics, financial impacts, or period-over-period comparisons are mentioned.

11-02-2026

Aquaron Acquisition Corp. filed an 8-K on February 11, 2026, under Item 1.01 disclosing entry into a material definitive agreement, likely related to a merger or acquisition, and Item 2.03 disclosing the creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as deal value, parties involved, valuation metrics, or financial terms are disclosed. No positive or negative performance metrics are provided, rendering the filing purely informational.

11-02-2026

M2i Global, Inc. filed an 8-K on February 11, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, metrics, or scheduled events are disclosed in the provided filing information.

11-02-2026

News Corp filed an 8-K on February 11, 2026 (AccNo: 0001564708-26-000032, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details disclosed on the nature of the 'Other Events' or contents of the exhibits. No quantitative metrics, financial impacts, or strategic information are provided.

11-02-2026

Moderna, Inc. filed an 8-K on February 11, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure, other events, or exhibits are provided. No financial metrics, transactions, or operational updates are disclosed.

• ·Filing Accession Number: 0001682852-26-000012
• ·Filing Size: 174 KB

11-02-2026

Prospect Capital Corp filed an 8-K on 2026-02-11 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, financial impacts, or strategic rationale are provided. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

11-02-2026

Transocean Ltd. filed an 8-K on February 11, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with voluntary disclosure under Regulation FD, but specific details of the disclosure, financial statements, exhibits, or any metrics are NOT_DISCLOSED in the provided filing summary.

11-02-2026

Vishay Precision Group, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits attached.

11-02-2026

Taylor Morrison Home Corp filed a Form 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons in the available information. No positive or negative metrics are mentioned.

11-02-2026

Upstream Bio, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, positive developments, negative impacts, or flat performance indicators are detailed in the provided filing summary. This appears to be a multi-item informational filing without disclosed quantitative data or directional implications.

11-02-2026

NiSource Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001111711-26-000026), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results disclosure. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics were disclosed in the provided filing information.

11-02-2026

SharkNinja, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001957132-26-000009, Size: 507 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure, but detailed results are NOT_DISCLOSED.

11-02-2026

Target Corp filed a Form 8-K on February 11, 2026 (AccNo: 0000027419-26-000009, Size: 156 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are detailed in the provided filing information. This is a standard earnings-related disclosure, but lacks quantitative metrics for performance assessment.

11-02-2026

Parsons Corp filed an 8-K on February 11, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits, announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is an informational disclosure without detailed financial data.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·Event type: Financial Results
• ·Filed: 2026-02-11, AccNo: 0001193125-26-045483

11-02-2026

Tenet Healthcare Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.

11-02-2026

CHIMERA INVESTMENT CORP filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

11-02-2026

Designer Brands Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the officer position, name, reason for change, or any quantitative data are disclosed.

11-02-2026

TransDigm Group INC filed a Form 8-K on February 11, 2026 (AccNo: 0001260221-26-000025, Size: 160 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing excerpt. This is a voluntary, single-item filing with no quantitative data or period-over-period comparisons mentioned.

11-02-2026

Humana Inc filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are disclosed in the provided filing information.

11-02-2026

Smurfit Westrock plc filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-012986), furnishing information under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing announces financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics in the available details. No positive or negative performance indicators, period-over-period comparisons, or material impacts are disclosed.

11-02-2026

Science Applications International Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific revenue, earnings, or other metrics are NOT_DISCLOSED in the provided information. No period-over-period comparisons, guidance, or other quantitative details are available.

11-02-2026

Ryder System Inc filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed results available.

11-02-2026

BLACKSTONE MORTGAGE TRUST, INC. filed an 8-K on 2026-02-11 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing represents a standard voluntary earnings release with no specific revenue, earnings, balance sheet, or period-over-period metrics detailed in the provided information. No positive or negative performance indicators, guidance, or comparisons were disclosed.

11-02-2026

Centrus Energy Corp filed a Form 8-K on 2026-02-11 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, financial impacts, or other metrics are disclosed.

11-02-2026

Kraft Heinz Co filed an 8-K on February 11, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.

11-02-2026

DANA Inc filed an 8-K on February 11, 2026, specifically under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached exhibits such as a press release or presentation. No quantitative financial metrics, transaction details, guidance, or operational changes are disclosed in the provided filing information.

• ·Accession Number: 0000950142-26-000333
• ·File Size: 239 KB

11-02-2026

Pyxus International, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0000939930-26-000010), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.

11-02-2026

TEREX CORP filed a Form 8-K on February 11, 2026 (AccNo: 0000097216-26-000028), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for quarterly or annual financial results announcements. No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are disclosed in the provided filing metadata.

11-02-2026

Sound Point Meridian Capital, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, or financial metrics disclosed in the provided information. No positive or negative metrics are mentioned.

• ·Accession Number: 0001829126-26-001232
• ·Sector: not specified

11-02-2026

Shopify Inc. filed a Form 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics in the available summary. No positive or negative performance details, period-over-period changes, or forward-looking statements are explicitly stated.

11-02-2026

Healthcare Services Group Inc filed an 8-K on February 11, 2026 (AccNo: 0000731012-26-000004), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard earnings-related disclosure with attached exhibits for further review.

• ·Filing size: 805 KB
• ·Sector: not specified

11-02-2026

Martin Marietta Materials Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-045530, Size: 2 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely disclosing earnings or financial results with attached exhibits, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or directional indicators are provided in the summary.

11-02-2026

Unity Software Inc. filed an 8-K on February 11, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are available.

11-02-2026

Neumora Therapeutics, Inc. filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, suggesting attachments were included. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts disclosed.

11-02-2026

Generac Holdings Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001437749-26-003700), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results with attached exhibits such as press releases. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

11-02-2026

VERU INC. filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the filing description. This appears to be a standard earnings-related disclosure with no quantified financial impacts provided.

11-02-2026

Crown Crafts Inc filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with no quantified performance data available.

11-02-2026

Precision BioSciences Inc filed a Form 8-K on February 11, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing likely includes voluntary disclosures and attached exhibits, such as a press release. No specific core events, financial metrics, transaction details, or quantitative data are disclosed in the provided filing metadata.

11-02-2026

Tempest Therapeutics, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-045543), disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. The filing is 18 MB in size, indicating potential material exhibits such as press releases or presentations. No specific financial metrics, transactions, operational data, positive or negative changes, or other details are provided in the filing summary.

11-02-2026

WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007113), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results from operations. No specific quantitative financial metrics, period-over-period changes, guidance, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

11-02-2026

Federal National Mortgage Association (Fannie Mae) filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative data were explicitly stated in the provided filing description. This is a standard informational disclosure for financial results with exhibits attached.

11-02-2026

Criteo S.A. filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics were disclosed in the provided filing information. This is an informational disclosure with no detailed performance data available.

11-02-2026

Hyperliquid Strategies Inc filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-045553), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with exhibits attached.

11-02-2026

Contango ORE, Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. The filing size is 9 MB, suggesting potential attachments, but content is NOT_DISCLOSED.

11-02-2026

Vertex, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013015), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. No positive or negative performance indicators, segment details, or comparisons are available.

11-02-2026

Great Lakes Dredge & Dock Corp filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-045567), disclosing under Item 1.01 entry into a material definitive agreement, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details, transaction values, personnel names, financial metrics, positive or negative changes, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item filing with no mentioned period-over-period comparisons or guidance revisions.

11-02-2026

T-Mobile US, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001283699-26-000007, Size: 8 MB), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, positive or negative metrics, or material changes were explicitly stated in the provided filing information. This is a standard disclosure for financial results with no directional financial data available.

11-02-2026

Royalty Pharma plc filed a Form 8-K on February 11, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. The filing appears informational with no quantitative details on performance variations available.

11-02-2026

Chefs' Warehouse, Inc. filed an 8-K on February 11, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item voluntary disclosure of financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed.

11-02-2026

Avantor, Inc. filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for financial results announcements, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. No positive or negative performance indicators, comparisons, or impacts are mentioned.

11-02-2026

Frontier Group Holdings, Inc. filed an 8-K on February 11, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without additional context on performance.

11-02-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on February 11, 2026 (AccNo: 0001493152-26-006114, size 6 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Reg FD and attachment of exhibits. No specific financial metrics, transactions, events, or quantitative details are disclosed in the provided filing information.

11-02-2026

Insight Molecular Diagnostics Inc. filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. All quantitative data and impacts are NOT_DISCLOSED.

11-02-2026

Urban One, Inc. filed an 8-K on February 11, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. No quantitative metrics, comparisons, or directional impacts are disclosed.

11-02-2026

CEMTREX INC filed an 8-K on February 11, 2026, disclosing the completion of an acquisition or disposition of assets under Item 2.01, along with other events under Item 8.01. Financial statements and exhibits are included under Item 9.01. No specific transaction details, financial metrics, parties involved, or impacts are disclosed.

11-02-2026

reAlpha Tech Corp. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-014591), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure for an unspecified sector, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided filing information. Critical financial data such as transaction values, percentages, or scheduled events remains NOT_DISCLOSED.

11-02-2026

Palo Alto Networks Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-045600), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative metrics, dollar values, strategic details, positive or negative impacts, or period-over-period comparisons are disclosed.

11-02-2026

LITHIA MOTORS INC filed an 8-K on 2026-02-11 (AccNo: 0001023128-26-000004, Size: 3 MB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with no specific metrics, transactions, or performance details disclosed. No positive, negative, or flat metrics are provided.

11-02-2026

Nuvectis Pharma, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013049), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or quantitative metrics are disclosed in the provided filing information. No positive or negative financial changes, guidance, or operational metrics were mentioned.

11-02-2026

Classover Holdings, Inc. filed an 8-K on February 11, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the other events, financial metrics, transactions, or impacts are provided in the filing summary. This is a multi-item informational filing with no quantitative data or directional implications disclosed.

11-02-2026

Worksport Ltd filed a Form 8-K on February 11, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the content of the disclosure, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational filing with no quantified positive or negative impacts disclosed.

11-02-2026

BorgWarner Inc filed an 8-K on February 11, 2026, under Item 2.02 reporting results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing summary. No period-over-period comparisons, guidance, or other quantitative details are available.

11-02-2026

NEXGEL, INC. filed a multi-item Form 8-K on 2026-02-11 reporting entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial terms are disclosed. The filing combines mandatory disclosures for significant corporate actions with voluntary Reg FD information.

11-02-2026

NNN REIT, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-045612), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details are disclosed in the provided filing information. This represents a standard earnings-related disclosure without directional performance indicators.

11-02-2026

La Rosa Holdings Corp. filed an 8-K on February 11, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are provided. This is a multi-item filing with no quantitative financial metrics, transactions, or performance data disclosed.

11-02-2026

HeartCore Enterprises, Inc. filed an 8-K on February 11, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, or period-over-period comparisons are detailed in the provided filing information. This appears to be a voluntary earnings-related disclosure with attached exhibits.

11-02-2026

Empery Digital Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons disclosed in the provided information. No quantitative data or strategic context is available for balanced assessment.

11-02-2026

Prudential Financial Inc filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing financial statements and exhibits. No specific details on the affected position, individual involved, reason for change, or timing are provided. No quantitative metrics, performance comparisons, or other financial data are mentioned.

11-02-2026

Atossa Therapeutics, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-045628, Size: 304 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure, financial metrics, transactions, or events are provided in the filing header. Sector is not specified.

• ·Multi-item 8-K filing (Items 7.01 and 9.01).
• ·Regulation FD Disclosure typically indicates voluntary sharing of material information.